ARTICLE | Company News
FDA accepts Indiplon NDA
July 27, 2005 12:44 AM UTC
FDA accepted for filing an NDA for Indiplon modified-release (MR) tablets from Neurocrine NBIX to treat insomnia in adult and elderly patients. The PDUFA date is March 27, 2006. An NDA for Indiplon im...